Electrophilic fatty acid nitroalkene derivatives, products of unsaturated fatty acid nitration, exert long-term cardiovascular protection in experimental models of metabolic and cardiovascular diseases. The goal of this study is to examine the effects of nitro-fatty acids in the regulation of upstream signalling events in nuclear factor-kB (NF-kB) activation and determine whether low-dose acute administration of nitro-fatty acids reduces vascular inflammation in vivo.
Introduction
During inflammatory responses, the nitrogen dioxide radical ( NO 2 can react with cell components including DNA bases, protein tyrosine residues, and unsaturated fatty acids to form relatively stable nitro derivatives. 1 It is viewed that protein tyrosine nitration during inflammation represents a shift from the signal transducing physiological actions of . NO to more pro-oxidative and pathogenic reactions. 1 In contrast, the nitration of unsaturated fatty acids represents a convergent redox signalling mechanism yielding electrophilic products that promote adaptive signalling responses. 2, 3 Nitro-fatty acids exert pluripotent cell signalling actions in the vasculature. 4 Electrophilic nitro-fatty acids participate in kinetically rapid protein adduction reactions by undergoing Michael additions, mainly with Cys and to a lesser extent His residues. 5, 6 In this manner, nitro-fatty acids form reversible adducts with critical electrophile-sensitive signalling mediators such as peroxisome proliferator-activated receptor-g (PPARg) 7, 8 and the Keap1 regulatory protein for Nrf2-dependent antioxidant response signalling. 9, 10 While nitroalkene derivatives of linoleic acid (LNO 2 ) and oleic acid (OA-NO 2 ) are potent partial agonists of PPARg and activators of Nrf2-dependent gene expression, current data support additional anti-inflammatory properties independent of PPARg and Nrf2. 11 -13 Notably, the electrophilic nature of nitro-fatty acids promote Michael addition to NF-kB signalling-related proteins, contributing to inhibition of inflammatory responses in vascular cells. 12 However, the precise mechanism by which nitroalkenes mediates suppression of NF-kB activity remains to be fully defined. Nitro-fatty acids are present as both free and nucleophile-adducted species in healthy human blood, with their endogenous levels at 1 nM for OA-NO 2 and isomers of LNO 2 .
14 Recent studies indicate that fatty acid nitration products are generated in vivo in myocytes following ischaemic preconditioning and focal ischaemia-reperfusion that actively participate in protein reactions. 15, 16 From current pharmacological viewpoints, chronic administration of nitroalkenes, in particular OA-NO 2 , mediate beneficial effects in experimental models of cardiovascular, inflammatory, and metabolic diseases. 8,17 -20 Also, in mice treated with LPS, OA-NO 2 administration attenuates systemic inflammation and limits multiorgan dysfunction. 21 In many of these studies, therapeutic benefit was achieved by long-term administration of pre-emptive OA-NO 2 . Herein, we reveal that an acute, low-dose in vivo administration of OA-NO 2 results in the rapid inhibition of NF-kB signalling. We show that OA-NO 2 disrupts toll-like receptor-4 (TLR4)-mediated signalling by altering the recruitment of adaptor proteins and upstream regulatory proteins of NF-kB into membrane lipid rafts of macrophages and endothelial cells. 
Methods

Animals
Total RNA preparation and RT-qPCR analysis
Total RNA was isolated from homogenized whole aortas of mice treated as above using TRIzol reagents (Invitrogen). RNA extraction and primer sequences are described in Supplementary material online, Methods and Supplementary material online, Table S1 .
Lipid rafts preparation
Lipid rafts fractions were separated from RAW 267.4 macrophages grown to confluence in 100 mm dishes. The homogenates in TNE buffer (TrisHCl, pH 7.4, 150 mM NaCl, 1 mM EDTA) containing 1% Triton X-100 were adjusted to 40% Optiprep (Sigma) in TNE lacking detergent and placed at the bottom of an ultracentrifuge tube. A 5 -30% discontinuous Optiprep gradient was formed above (4 mL of 5% Optiprep/4 mL of 30% Optiprep, both in TNE lacking detergent) and centrifuged at 134 000g for 4 h in a TH-641 rotor (Sorvall). Starting from the top, 12 subfractions were collected, precipitated in 10% TCA, and the distribution of individual Nitro-fatty acids alter inflammatory signalling in lipid rafts proteins in the gradient was detected by western blotting. Lipid rafts were identified with an anti-Flotillin antibody (BD Biosciences).
Western blot
Cell lysates were subjected to immunoblot as previously described.
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Antibodies against phospho-IkBa (Ser32/36) mouse monoclonal, phospho-IKKa/b (Ser176/180) rabbit were from Cell Signaling Technology. Antibodies against TLR4, IkB, ubiquitin, TRAF6, and GAPDH were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All primary antibodies were used at 1:1000 dilutions.
Confocal microscopy
HUVEC (Lonza) were cultured in four-chamber coverglass (Lab-Tek) and treated with OA or OA-NO 2 (2 mM) for 30 min. LPS (1 mg/mL) was added for 10 min before washing with PBS. Gangliosides enriched in lipid rafts were stained with Alexa594-labelled cholera toxin subunit-B (1 mg/mL, 1 h) (Molecular Probes). For dual-staining and colocalization of lipid rafts with the TLR4, HUVEC were further incubated with mouse anti-TLR4-Alexa Fluor 488 conjugated antibody (1 mg/mL, 1 h) (Santa Cruz). Nuclei were stained with DAPI (1 mg/mL, 10 min, Pierce).
Immunofluorescence was visualized with an Olympus FluoView 500 Laser Scanning Confocal Microscope. Images were obtained by an investigator blinded for the experimental treatments. Three independent fields were considered.
Statistics
Values are expressed as mean + SEM. The data were analysed using ANOVA with the Newman-Keuls' test. Values of P , 0.05 were considered statistically significant.
Results
Nitro-fatty acids inhibit LPS-induced aortic NF-kB activation
The physiological relevance of OA-NO 2 -mediated actions was tested in vivo by evaluating alterations in NF-kB reporter gene expression. Transgenic mice carrying a firefly luciferase reporter driven by a tandem repeat of three NF-kB binding sites were used. 22 Thioglycollate-derived peritoneal macrophages were isolated from NF-kB-luciferase transgenic mice to test the ability of OA-NO 2 to inhibit LPS-stimulated NF-kB activity in vitro ( Figure 1A) . After 6 h treatment with OA-NO 2 (2 mM), the firefly luminescence was significantly reduced in NF-kB-luciferase macrophages stimulated with LPS.
To test whether OA-NO 2 is similarly effective in reducing vascular NF-kB activity in vivo, OA-NO 2 or OA were delivered to NF-kB-luciferase transgenic mice via subcutaneously implanted osmotic minipumps. On the third day, mice were treated via tail-vein injection with LPS (0.5 mg/kg) for 3 h and NF-kB activity was directly measured from aortic tissue extracts. Low intravenous treatment with LPS caused a mild and transient decrease in cardiac +dP/dt and reduction of LV pressure, which is rapidly recovered within the first 10 min (Supplementary material online, Figure S1 ), thus averting many of the physiological effects of chronic endotoxaemia, which requires higher doses of LPS. 25 However, it is sufficient to induce vascular NF-kB activation ( Figure 1B) . Systemic delivery of OA-NO 2 significantly inhibited LPS-induced aortic NF-kB activation, whereas vehicle (PEG) and native OA had no effect ( Figure 1B ). These data demonstrate that pre-emptive delivery of OA-NO 2 potently inhibits vascular NF-kB activation upon exposure to pro-inflammatory stimuli.
Nitro-fatty acids inhibit LPS-induced leukocyte adhesion in vivo
Next, it was evaluated whether an acute treatment with OA-NO 2 exert similar in vivo anti-inflammatory effects. An inflammatory response was induced in mice by treatment with LPS, with a simultaneous single dose of either OA-NO 2 or OA (0.5 mmoles/kg) co-administered in some groups. At 3 h, mice were anaesthetized and the cremaster vasculature exposed for intravital videomicroscopy to evaluate the in vivo adhesion of leukocytes to the vessel wall ( Figure 1C , see accompanying Supplementary material online, Videos). As shown in Figure 1D , a single dose of OA-NO 2 significantly reduced the number of leukocytes adhered to the venular endothelium. An equivalent amount of non-nitrated OA had no effect. We have previously shown that OA-NO 2 delivery via osmotic minipump implantation induced, 20 nM steady state free nitro-fatty acid concentrations in plasma. 26 To address whether acute intravenous administration of OA-NO 2 yielded circulating levels sufficient to inhibit monocyte adhesion to the endothelium in vivo, blood samples were collected 3 h after mice were treated with LPS (0.5 mg/kg), LPS+OA or LPS+OA-NO 2 (0.5 mmoles/kg each). The concentration of OA-NO 2 and its major metabolites were quantified revealing plasma levels of 25 nM OA-NO 2 ( Figure 2) . In vivo metabolism of OA-NO 2 includes b-oxidation and inactivation of its electrophilic reactivity via the reduction of the nitroalkene OA-NO 2 to the nitroalkane product nitro-stearic acid (NO 2 -SA, the 2e 2 reduction product of OA-NO 2 ). Plasma NO 2 -SA reached 55 nM at 3 h (Figure 2A) . Detectable levels of the b-oxidation metabolites NO 2 -14:0 and NO 2 -14:1 were also observed ( Figure 2B) , consistent with previous studies on the metabolism of nitro-fatty acids. 24 Free OA-NO 2 and NO 2 -SA were below quantifiable levels in the LPS and LPS+OA groups ( Figure 2C ). Nitro-fatty acids alter inflammatory signalling in lipid rafts
Nitro-fatty acids inhibit LPS-induced TLR4 cell surface expression and vascular adhesion in vivo
Under these acute conditions, TLR4 cell surface expression was determined by FACS analysis in monocytes isolated from the peritoneal cavity ( Figure 3A) . LPS-induced TLR4 cell surface recruitment was impaired after a simultaneous intravenous injection of OA-NO 2 , whereas control-administration of OA had no effect ( Figure 3B) . Moreover, aortic mRNA expression of vascular (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), E-selectin, and inducible NO synthase (iNOS) was significantly reduced upon OA-NO 2 treatment ( Figure 3C) . Notably, TLR4 mRNA levels were unchanged. Collectively, these data demonstrate that an acute treatment with OA-NO 2 , yielding nanomolar concentrations, exert a robust anti-inflammatory response and is sufficient to inhibit vascular NF-kB activation and recruitment of the upstream TLR4 to the cell membrane. These particular responses are not attributed to transcriptional regulation events, e.g. PPARg activation, because of the rapidity of the response kinetics and the fact that PPARg activity was not significantly induced upon acute treatment with OA-NO 2 (Supplementary material online, Figure S2 ).
Nitro-fatty acids suppress IKK/IkB signalling in endothelial cells and macrophages
The observed inhibition of NF-kB signalling led us to propose a direct interference of OA-NO 2 with upstream signalling reactions leading to NF-kB activation. OA-NO 2 dose-dependently inhibited LPS-induced phosphorylation of IkBa in RAW264.7 macrophages, whereas control treatments with OA did not alter IkB phosphorylation ( Figure 4A) . This was further supported by HUVEC responses, where OA-NO 2 inhibited LPS-induced phosphorylation and subsequent degradation of IkBa in a time-dependent manner ( Figure 4B) . Moreover, OA-NO 2 interfered with LPS-induced IkBa ubiquitination (Supplementary material online, Figure S3) . Notably, phosphorylation of IKK was also suppressed by OA-NO 2 ( Figure 4C ). These data reveal that OA-NO 2 suppresses pro-inflammatory activation of IkB/IKK, upstream events in the NF-kB signalling pathway. Confirmatory experiments also showed that nitro-fatty acids similarly represses upstream signalling events of the NF-kB pathway in endothelial cells (Supplementary material online, Figure S4 ). 
Nitro-fatty acids disrupt the assembly of the TLR4 signalling complex in lipid rafts
Lipid raft microdomains serve as discrete membrane regions that coordinate initial signalling events essential for TLR4-mediated inflammatory responses. 27, 28 Thus, we isolated bouyant lipid-raft fractions from RAW264.7 macrophages by flotation on a discontinuous sucrosedensity gradient and explored whether OA-NO 2 affect LPS-induced trafficking of TLR4-associated signalling mediators to lipid rafts. In unstimulated macrophages, TLR4 and TRAF6 preferentially localized in high-density non-lipid raft fractions, whereas LPS induced a rapid recruitment of TLR4 and TRAF6 to flotillin-1-rich fractions, a protein constitutively expressed in lipid rafts 28 ( Figure 5A ). In contrast, OA-NO 2 , but not OA, significantly inhibited LPS-induced migration of TLR4 and TRAF6 to the light lipid raft fractions ( Figure 5A ). To further evaluate colocalization of TLR4 with lipid raft microdomains, TLR4 recruitment into lipid rafts was visualized in HUVECs by confocal microscopy, using cholera toxin B as a surrogate marker of lipid rafts. LPS treatment induced TLR4 colocalization into lipid rafts, which was significantly inhibited by treatment with OA-NO 2 but not OA ( Figure 5B ). For comparison, methyl-b-cyclodextrin (MbCD), an inhibitor of lipid raft formation by depleting membrane cholesterol was used 29 (Supplementary material online, Figure S5 ).
To corroborate these findings, we compared the LPS-induced IkBa phosphorylation in macrophages treated with OA-NO 2 and MbCD. MbCD inhibited LPS-mediated IkBa phosphorylation in a dosedependent manner, whereas phosphorylation of IkBa was significantly inhibited by OA-NO 2 (Supplementary material online, Figure S5 ). In aggregate, these results indicate that OA-NO 2 inhibits the lipid raft assembly of TLR4 signalling and adaptor molecules, upstream events of the NF-kB pathway. Taken together, these studies provide the first evidence that OA-NO 2 impairs lipid raft-dependent clustering of pro-inflammatory initial signalling in vascular cells leading to resolution of pro-inflammatory vascular activation of NF-kB.
Discussion
Exogenously administered nitro-fatty acids display protective antiinflammatory actions in a variety of models of cardiovascular disease. In ApoE knockout mice treated with nitro-fatty acids, the with LPS (1 mg/mL), and increasing concentrations of OA-NO 2 , as indicated. Cell lysates were subjected to western blot analysis using p-IkBa antibody and GAPDH to determine protein loading. Quantitative densitometry analysis is shown. n ¼ 4. (B) HUVEC treated with LPS (1 mg/mL) or LPS+ OA-NO 2 (2 mM) for different times as indicated. Cell lysates were subjected to western blot analysis using antibodies against p-IkBa, IkBa, IKKa, and GAPDH. Quantitative densitometry analysis is shown. n ¼ 4. *P , 0.05 vs. control, **P , 0.05 vs. LPS+OA-NO 2 . (C) Western blot analysis of p-IKKa/b, IKKa, IKKb, and GAPDH of HUVECs treated as in (B). Quantitative densitometry analysis is shown. n ¼ 4.
Nitro-fatty acids alter inflammatory signalling in lipid rafts onset and progression of atherosclerosis and the expression of cell adhesion molecules are significantly reduced. 18 This potent antiinflammatory role of nitro-fatty acids on the adhesion of monocytes was also examined in vitro when applying physiological flow-mediated forces to endothelial cells. 12 Subsequent experiments using phorbol 12-myristate 13-acetate and N-formyl-Met-Leu-Phe-activated human neutrophils and bone marrow-derived macrophages from ApoE deficient mice indicated that OA-NO 2 reduced LPS-induced superoxide generation and inflammation in vitro. 11, 18 In most of these studies, the reduction of the inflammatory response was observed when nitro-fatty acids are pre-emptively delivered, with the relevant exception regarding the ability of OA-NO 2 to form adducts with the angiotensin II receptor, significantly reducing pre-existing hypertension. 19 Herein, we show that (i) a single dose of OA-NO 2 reduces the adhesion of inflammatory cells to the vasculature and (ii) acute nanomolar concentrations of OA-NO 2 are sufficient to suppress NF-kB activity in vivo in response to pro-inflammatory LPS stimulation.
NF-kB is sequestered in the cytoplasm by its binding to inhibitory proteins, e.g. IkB. In response to inflammatory cytokines, mitogens, and LPS, activation of NF-kB is mediated by a signalling cascade that results in phosphorylation of IkB by an IkB kinase (IKK) complex composed of IKKa, IKKb, and IKKg, the activity of which results in the release and proteasomal degradation of IkB. 30 These phosphorylation events are highly dependent on the initial formation of specialized lipid raft microdomains in the membrane. 31 Lipid rafts are rich in cholesterol and sphingolipids, and serve as platforms for conducting a variety of cellular functions. 32 Lipid rafts and their subsets, caveolae, play a central role in the regulation of the cardiovascular function, inflammation, and immune responses. 33 Lipid raft clustering contributes to endothelial dysfunction 34 and enhances redox signalling mediated by NAD(P)H oxidases, 35 all of which are early events in the onset of atherosclerosis. For instance, TLR4-mediated inflammatory responses significantly contribute to early atherosclerosis development. 36 T-cell receptor-induced NF-kB activation involves lipid raft OA (2 mM), or OA-NO 2 (2 mM) for 5 min. Lipid rafts fractions were separated using buoyant gradient density centrifugation. Migration of TLR4 and TRAF6 into light density fractions corresponding to lipid raft was analysed by western blot and identified using an anti-flotillin-1 antibody. (B) Densitometric analysis of TLR4 and TRAF6 mobility into lipid rafts (Fractions 4 and 5). n ¼ 3. *P , 0.05 vs. control, **P , 0.05 LPS vs. LPS+OA-NO 2 .
(C) HUVEC were treated with LPS (1 mg/mL), OA (2 mM), or OA-NO 2 (2 mM) for 5 min. Recruitment of TLR4 into lipid rafts was determined by confocal microscopy using dual-staining against TLR4-Alexa 488 (green-left panels) and cholera toxin subunit B-Alexa Fluor 594 conjugated (red-middle panels), to visualize GPI-rich domains characteristic of lipid rafts. Nuclei were stained with DAPI (blue-right panels). Bar ¼ 10 mm.
recruitment of the IKK complex. 37 In mice deficient in sphingomyelin synthase 2, in which lipid raft formation is impaired, NF-kB activation and its target gene expression are attenuated in macrophages. 38 In the present study, we demonstrate that the electrophilic nitroalkene derivatives of oleic acid, OA-NO 2 , preferentially impair the recruitment of the TLR4 into lipid raft compared with their nonnitrated counterparts and disrupt the assembly of adaptor proteins TRAF6/IKKb/IkBa complex. As a consequence, vascular activation of the NF-kB upstream kinases IKKb and IkB is impaired. Fatty acid composition plays a critical role in lipid raft formation and initiation of inflammatory signalling. 39 Unsaturated fatty acids prevent anti-inflammatory signalling recruitment into lipid rafts. 40 It has been proposed that saturated but not unsaturated fatty acids bind to the TLR4 receptor, promoting receptor dimerization and subsequent downstream signalling. 41 On the other hand, unsaturated fatty acid supplementation alters the acyl composition of lipid rafts. 42 In our experimental conditions, OA had no significant effect in the recruitment of TLR4 and adaptor proteins into lipid rafts and did not inhibit NF-kB signalling. Thus, redox-dependent modification of these fatty acids confers them with electrophilic properties advantageous to prevent the initial generation of a focal inflammatory 'signalosome'. 43 Alternatively, the electrophilic nature of nitro-fatty acids may directly neutralize ligands for TLR-signalling. 44 Thus, nitro-fatty acids are able to disrupt TLR4 initial signalling and the assembly of TRAF6/IKK recruitment into lipid rafts, which may facilitate the subsequent nitroalkylation of NF-kB proteins, 12 ultimately leading to inactivation of the pro-inflammatory NF-kB cascade in vascular cells ( Figure 6 ). In this regard, the electrophilic properties of nitro-fatty acids, while more potent, resemble those of unsaturated a,b-unsaturated ketones such as 15-deoxy-D 12,14 -prostaglandin-J 2 (15d-PGJ 2 ), which is also able to directly inhibit upstream IkB kinase (IKK). 45 OA-NO 2 , like 15d-PGJ 2 , is a PPARg ligand, and as such limit chronic inflammation by interfering with NF-kB transcriptional activity. 46 However, our findings that PPARg activity is not altered by acute delivery of OA-NO 2 rather indicate a direct effect on NF-kB signalling. The effects on other inflammatory signalling molecules that are also inhibited by OA-NO 2 (for review see Baker et al.
2
) and are highly dependent on lipid raft formation (e.g JAK/STAT) 47 cannot be fully excluded.
Further studies will be needed to clarify their contribution to the antiinflammatory properties of nitroalkenes. In aggregate, we provide experimental evidence that an acute treatment with electrophilic OA-NO 2 , yielding nanomolar plasma levels reduces vascular inflammatory responses, adhesion of immune cells to the vascular endothelium, and NF-kB activation. These in vivo observations reinforce the concept that nitro-fatty acids are potent signalling mediators that act to resolve inflammation 4, 48 and that the nitration or oxygenation of unsaturated fatty acids to yield electrophilic products during inflammation can transduce the actions of unsaturated fatty acids. 49 These actions occur via both the acute responses described herein and as a consequence of the transcriptional activation of other cellular responses. 50 Thus, synthetic homologues of this lipid class holds promise as a therapeutic strategy for treating cardiovascular disease.
Supplementary material
Supplementary material is available at Cardiovascular Research online. 
Figure 6
Nitroalkenes interfere with NF-kB signalling in lipid rafts. Engagement of pro-inflammatory ligands, e.g. LPS to the TLR4, initiates the recruitment of signalling molecules into lipid rafts, where ligand-mediated signalling complex is assembled to activate NF-kB signalling. Free nitroalkenes disrupt the assembly of the initial signalling molecules into lipid rafts, which may facilitate further nitroalkylation of NF-kB proteins, ultimately leading to inactivation of vascular pro-inflammatory and adhesion molecules.
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